Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Cash from Financing Activities (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed Cash from Financing Activities for 8 consecutive years, with -$4.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Cash from Financing Activities fell 922.99% to -$4.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.1 million, a 22.52% increase, with the full-year FY2024 number at $6.4 million, up 21.93% from a year prior.
  • Cash from Financing Activities was -$4.4 million for Q3 2025 at SANUWAVE Health, down from $161000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $6.5 million in Q4 2024 to a low of -$4.4 million in Q3 2025.
  • A 3-year average of $656272.7 and a median of $161000.0 in 2025 define the central range for Cash from Financing Activities.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 248.95% in 2024, then crashed 922.99% in 2025.
  • SANUWAVE Health's Cash from Financing Activities stood at $1.9 million in 2023, then surged by 248.95% to $6.5 million in 2024, then plummeted by 168.75% to -$4.4 million in 2025.
  • Per Business Quant, the three most recent readings for SNWV's Cash from Financing Activities are -$4.4 million (Q3 2025), $161000.0 (Q2 2025), and -$57000.0 (Q1 2025).